Abstract
This report describes a persistent SARS-CoV-2 infection of at least 218 days in a male, in his 40’s who had undergone a prior autologous hematopoietic stem cell transplant due to a diffuse large B-cell lymphoma. He did not manifest a humoral immune response to the virus. Whole-genome sequencing and viral cultures confirmed a continual infection with a replication-positive virus that had undergone genetic variation for at least 196 days following symptom onset.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Authors or institutions involved did not receive any payments or services in the past from a third party that could be perceived to influence, or give the appearance of potentially influencing, the submitted work. This work was supported by a grant from Sao Paulo Research Foundation (FAPESP Grant Number:2020/05623-0). This work was also supported by a Medical Research Council-Sao Paulo Research Foundation (FAPESP) CADDE partnership award (MR/S0195/1 and FAPESP 18/14389-0) (caddecentre.org/). N.R. F is supported by Wellcome Trust and Royal Society (Sir Henry Dale Fellowship: 204311/Z/16/Z).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All relevant ethical guidelines have been followed. The study was approved by the local ethics committee :Comissao Nacional de Etica em Pesquisa do Ministerio da Saude do Brasil (CONEP), protocol No. 30419320.7.0000.0068, dated April 18, 2020) and all subjects provided informed written consent. Ethical approval was given to the project. All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived. Authors or institutions involved did not receive any payments or services in the past from a third party that could be perceived to influence, or give the appearance of potentially influencing, the submitted work. This work was supported by a grant from Sao Paulo Research Foundation (FAPESP Grant Number:2020/05623-0). This work was also supported by a Medical Research Council-Sao Paulo Research Foundation (FAPESP) CADDE partnership award (MR/S0195/1 and FAPESP 18/14389-0) (caddecentre.org/). N.R. F is supported by Wellcome Trust and Royal Society (Sir Henry Dale Fellowship: 204311/Z/16/Z).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data that support the findings of this study are available from the corresponding author, upon request.
